nodes	percent_of_prediction	percent_of_DWPC	metapath
Mephentermine—Lacosamide—Nateglinide—type 2 diabetes mellitus	0.189	0.242	CrCrCtD
Mephentermine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.17	1	CbGbCtD
Mephentermine—Phenacemide—Nateglinide—type 2 diabetes mellitus	0.128	0.164	CrCrCtD
Mephentermine—Amphetamine—Nateglinide—type 2 diabetes mellitus	0.124	0.159	CrCrCtD
Mephentermine—Dextroamphetamine—Nateglinide—type 2 diabetes mellitus	0.124	0.159	CrCrCtD
Mephentermine—Methamphetamine—Nateglinide—type 2 diabetes mellitus	0.121	0.155	CrCrCtD
Mephentermine—L-Phenylalanine—Nateglinide—type 2 diabetes mellitus	0.0947	0.121	CrCrCtD
Mephentermine—Phenformin—PRKAA1—type 2 diabetes mellitus	0.00188	0.267	CrCbGaD
Mephentermine—Amphetamine—CARTPT—type 2 diabetes mellitus	0.00146	0.208	CrCbGaD
Mephentermine—Phenelzine—AOC3—type 2 diabetes mellitus	0.00117	0.167	CrCbGaD
Mephentermine—Tolazoline—ADRA2A—type 2 diabetes mellitus	0.000356	0.0506	CrCbGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—MTNR1A—type 2 diabetes mellitus	0.00031	0.00753	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GCGR—type 2 diabetes mellitus	0.00031	0.00752	CbGpPWpGaD
Mephentermine—ADRA1A—Calcium Regulation in the Cardiac Cell—ATP2A3—type 2 diabetes mellitus	0.000306	0.00742	CbGpPWpGaD
Mephentermine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB3—type 2 diabetes mellitus	0.000286	0.00695	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—type 2 diabetes mellitus	0.000285	0.00692	CbGpPWpGaD
Mephentermine—ADRA1A—Endothelin Pathways—NOS3—type 2 diabetes mellitus	0.000281	0.00682	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MTNR1A—type 2 diabetes mellitus	0.000266	0.00645	CbGpPWpGaD
Mephentermine—Pseudoephedrine—ADRA2A—type 2 diabetes mellitus	0.000263	0.0374	CrCbGaD
Mephentermine—ADRA1A—G alpha (12/13) signalling events—GNB3—type 2 diabetes mellitus	0.000255	0.00619	CbGpPWpGaD
Mephentermine—Pseudoephedrine—TNF—type 2 diabetes mellitus	0.000249	0.0354	CrCbGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—MC4R—type 2 diabetes mellitus	0.000225	0.00547	CbGpPWpGaD
Mephentermine—ADRA1A—Calcium Regulation in the Cardiac Cell—ATP2A2—type 2 diabetes mellitus	0.000219	0.00533	CbGpPWpGaD
Mephentermine—ADRA1A—AMPK Signaling—LEP—type 2 diabetes mellitus	0.000208	0.00505	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—MTNR1A—type 2 diabetes mellitus	0.000202	0.00491	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—CCKAR—type 2 diabetes mellitus	0.000202	0.00491	CbGpPWpGaD
Mephentermine—Methamphetamine—ADRA2A—type 2 diabetes mellitus	0.000197	0.0281	CrCbGaD
Mephentermine—Benzyl alcohol—CYP2E1—type 2 diabetes mellitus	0.000195	0.0278	CrCbGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.000193	0.00469	CbGpPWpGaD
Mephentermine—Phentermine—CYP1A2—type 2 diabetes mellitus	0.000192	0.0274	CrCbGaD
Mephentermine—Selegiline—CYP2E1—type 2 diabetes mellitus	0.000187	0.0266	CrCbGaD
Mephentermine—Benzyl alcohol—CYP1A2—type 2 diabetes mellitus	0.000186	0.0264	CrCbGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB3—type 2 diabetes mellitus	0.000184	0.00448	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—type 2 diabetes mellitus	0.000181	0.00439	CbGpPWpGaD
Mephentermine—Selegiline—CYP1A2—type 2 diabetes mellitus	0.000178	0.0253	CrCbGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—TRPC6—type 2 diabetes mellitus	0.000178	0.00431	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.000175	0.00424	CbGpPWpGaD
Mephentermine—ADRA1A—AMPK Signaling—AKT2—type 2 diabetes mellitus	0.000172	0.00417	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—EDNRB—type 2 diabetes mellitus	0.000169	0.00411	CbGpPWpGaD
Mephentermine—Phenelzine—CYP2E1—type 2 diabetes mellitus	0.000165	0.0235	CrCbGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—HTR2C—type 2 diabetes mellitus	0.000164	0.00399	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—MTNR1B—type 2 diabetes mellitus	0.000163	0.00395	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—GIPR—type 2 diabetes mellitus	0.000161	0.0039	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—EDNRA—type 2 diabetes mellitus	0.00016	0.00388	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—type 2 diabetes mellitus	0.000159	0.00386	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	0.000158	0.00384	CbGpPWpGaD
Mephentermine—ADRA1A—Calcium Regulation in the Cardiac Cell—GJA1—type 2 diabetes mellitus	0.000157	0.00382	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCKAR—type 2 diabetes mellitus	0.000156	0.00379	CbGpPWpGaD
Mephentermine—ADRA1A—AMPK Signaling—PIK3R1—type 2 diabetes mellitus	0.000156	0.00378	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—GHRL—type 2 diabetes mellitus	0.000156	0.00378	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—type 2 diabetes mellitus	0.000151	0.00367	CbGpPWpGaD
Mephentermine—ADRA1A—Calcium Regulation in the Cardiac Cell—GNB3—type 2 diabetes mellitus	0.000147	0.00357	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—MC4R—type 2 diabetes mellitus	0.000147	0.00357	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—type 2 diabetes mellitus	0.000147	0.00356	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (12/13) signalling events—PIK3R1—type 2 diabetes mellitus	0.000146	0.00354	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—type 2 diabetes mellitus	0.000143	0.00347	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—GCG—type 2 diabetes mellitus	0.000142	0.00346	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—GIP—type 2 diabetes mellitus	0.000141	0.00344	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—RASGRP1—type 2 diabetes mellitus	0.00014	0.0034	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	0.00014	0.00339	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—type 2 diabetes mellitus	0.000139	0.00338	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	0.000136	0.00331	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	0.000134	0.00325	CbGpPWpGaD
Mephentermine—ADRA1A—Calcium Regulation in the Cardiac Cell—ADCY5—type 2 diabetes mellitus	0.000131	0.00318	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	0.000131	0.00317	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 2 diabetes mellitus	0.000127	0.00309	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	0.000127	0.00308	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—type 2 diabetes mellitus	0.000125	0.00304	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	0.000123	0.003	CbGpPWpGaD
Mephentermine—Benzyl alcohol—CYP3A4—type 2 diabetes mellitus	0.000123	0.0175	CrCbGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—GNB3—type 2 diabetes mellitus	0.000123	0.00298	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—AVP—type 2 diabetes mellitus	0.000121	0.00294	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	0.000121	0.00293	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.00012	0.00292	CbGpPWpGaD
Mephentermine—Selegiline—CYP3A4—type 2 diabetes mellitus	0.000118	0.0168	CrCbGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	0.000117	0.00284	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.000116	0.00282	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—EDN1—type 2 diabetes mellitus	0.000115	0.0028	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.000114	0.00278	CbGpPWpGaD
Mephentermine—ADRA1A—Calcium Regulation in the Cardiac Cell—CALM1—type 2 diabetes mellitus	0.000113	0.00274	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.000112	0.00272	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNB3—type 2 diabetes mellitus	0.00011	0.00266	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.000109	0.00264	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—type 2 diabetes mellitus	0.000108	0.00263	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—type 2 diabetes mellitus	0.000108	0.00263	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.000106	0.00258	CbGpPWpGaD
Mephentermine—ADRA1A—Calcium Regulation in the Cardiac Cell—PRKCB—type 2 diabetes mellitus	0.000106	0.00257	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.000106	0.00257	CbGpPWpGaD
Mephentermine—Phenelzine—CYP3A4—type 2 diabetes mellitus	0.000104	0.0148	CrCbGaD
Mephentermine—ADRA1A—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.000104	0.00252	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.000104	0.00251	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.000103	0.00251	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.000103	0.0025	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—type 2 diabetes mellitus	0.000103	0.0025	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.000102	0.00247	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	9.87e-05	0.0024	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—AGT—type 2 diabetes mellitus	9.55e-05	0.00232	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—IAPP—type 2 diabetes mellitus	9.17e-05	0.00223	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	9.08e-05	0.00221	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	9.08e-05	0.00221	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—GCGR—type 2 diabetes mellitus	8.96e-05	0.00218	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	8.91e-05	0.00216	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	8.55e-05	0.00207	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	8.53e-05	0.00207	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—ARAP1—type 2 diabetes mellitus	8.48e-05	0.00206	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	8.31e-05	0.00202	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	8.28e-05	0.00201	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—GIPR—type 2 diabetes mellitus	8.25e-05	0.002	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—GRK5—type 2 diabetes mellitus	8.25e-05	0.002	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	8.05e-05	0.00196	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	8.02e-05	0.00195	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—GIP—type 2 diabetes mellitus	8e-05	0.00194	CbGpPWpGaD
Mephentermine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	7.95e-05	0.00193	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	7.88e-05	0.00191	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—GHRL—type 2 diabetes mellitus	7.85e-05	0.00191	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—VPS26A—type 2 diabetes mellitus	7.76e-05	0.00188	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—CALCA—type 2 diabetes mellitus	7.75e-05	0.00188	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	7.62e-05	0.00185	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—MC4R—type 2 diabetes mellitus	7.54e-05	0.00183	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—GIP—type 2 diabetes mellitus	7.26e-05	0.00176	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—GCG—type 2 diabetes mellitus	7.18e-05	0.00174	CbGpPWpGaD
Mephentermine—ADRA1A—AMPK Signaling—AKT1—type 2 diabetes mellitus	7.16e-05	0.00174	CbGpPWpGaD
Mephentermine—ADRA1A—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	7.01e-05	0.0017	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	6.82e-05	0.00165	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	6.8e-05	0.00165	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	6.66e-05	0.00162	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	6.57e-05	0.00159	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	6.33e-05	0.00154	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	6.27e-05	0.00152	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—GNB3—type 2 diabetes mellitus	6.19e-05	0.0015	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	6.17e-05	0.0015	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	6.13e-05	0.00149	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—AVP—type 2 diabetes mellitus	6.1e-05	0.00148	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	6.01e-05	0.00146	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	5.96e-05	0.00145	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	5.85e-05	0.00142	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—EDN1—type 2 diabetes mellitus	5.81e-05	0.00141	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	5.76e-05	0.0014	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	5.45e-05	0.00132	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	5.31e-05	0.00129	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—GCGR—type 2 diabetes mellitus	5.29e-05	0.00129	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	5.23e-05	0.00127	CbGpPWpGaD
Mephentermine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	5.21e-05	0.00127	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—CCR5—type 2 diabetes mellitus	5.19e-05	0.00126	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	5.18e-05	0.00126	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—C3—type 2 diabetes mellitus	5.07e-05	0.00123	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	5.06e-05	0.00123	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	5.03e-05	0.00122	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—GRK5—type 2 diabetes mellitus	4.87e-05	0.00118	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—GIPR—type 2 diabetes mellitus	4.87e-05	0.00118	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	4.82e-05	0.00117	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—AGT—type 2 diabetes mellitus	4.82e-05	0.00117	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—IAPP—type 2 diabetes mellitus	4.71e-05	0.00114	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	4.68e-05	0.00114	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	4.6e-05	0.00112	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	4.57e-05	0.00111	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	4.55e-05	0.00111	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—MC4R—type 2 diabetes mellitus	4.46e-05	0.00108	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	4.45e-05	0.00108	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	4.44e-05	0.00108	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	4.38e-05	0.00106	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	4.38e-05	0.00106	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—GIP—type 2 diabetes mellitus	4.29e-05	0.00104	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	4.25e-05	0.00103	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	4.13e-05	0.001	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—LEPR—type 2 diabetes mellitus	4.08e-05	0.00099	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	4.07e-05	0.000988	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—GCG—type 2 diabetes mellitus	4.06e-05	0.000985	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	4.04e-05	0.000982	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—GHRL—type 2 diabetes mellitus	4.03e-05	0.000978	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	3.99e-05	0.000969	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—CALCA—type 2 diabetes mellitus	3.98e-05	0.000966	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR ligand binding—CCL2—type 2 diabetes mellitus	3.97e-05	0.000964	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	3.89e-05	0.000946	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—TLE4—type 2 diabetes mellitus	3.79e-05	0.00092	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—GCG—type 2 diabetes mellitus	3.68e-05	0.000894	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—ADRB3—type 2 diabetes mellitus	3.65e-05	0.000886	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	3.62e-05	0.00088	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—CRHR1—type 2 diabetes mellitus	3.52e-05	0.000855	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	3.5e-05	0.000849	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—AVP—type 2 diabetes mellitus	3.45e-05	0.000838	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	3.28e-05	0.000797	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	3.25e-05	0.000789	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—SPRY2—type 2 diabetes mellitus	3.22e-05	0.000782	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	3.22e-05	0.000782	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—GNB3—type 2 diabetes mellitus	3.18e-05	0.000771	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.14e-05	0.000762	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.14e-05	0.000762	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—AVP—type 2 diabetes mellitus	3.13e-05	0.000761	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—MMP3—type 2 diabetes mellitus	3.13e-05	0.000761	CbGpPWpGaD
Mephentermine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	3.13e-05	0.000759	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.12e-05	0.000757	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.09e-05	0.00075	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—EDN1—type 2 diabetes mellitus	2.98e-05	0.000723	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	2.93e-05	0.000712	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—C3—type 2 diabetes mellitus	2.87e-05	0.000696	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	2.83e-05	0.000687	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	2.8e-05	0.000679	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—IAPP—type 2 diabetes mellitus	2.78e-05	0.000675	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—INSR—type 2 diabetes mellitus	2.76e-05	0.000671	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—AGT—type 2 diabetes mellitus	2.72e-05	0.000661	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—TRPC6—type 2 diabetes mellitus	2.72e-05	0.000659	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	2.71e-05	0.000659	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—AGTR2—type 2 diabetes mellitus	2.7e-05	0.000656	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	2.66e-05	0.000647	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—C3—type 2 diabetes mellitus	2.6e-05	0.000632	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	2.59e-05	0.000628	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.52e-05	0.000611	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.51e-05	0.000609	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.51e-05	0.000609	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.47e-05	0.0006	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.44e-05	0.000593	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.43e-05	0.00059	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.43e-05	0.00059	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.39e-05	0.00058	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.38e-05	0.000578	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.38e-05	0.000578	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.35e-05	0.000571	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.29e-05	0.000555	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.21e-05	0.000537	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.2e-05	0.000535	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—GCG—type 2 diabetes mellitus	2.18e-05	0.000528	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.18e-05	0.000528	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.14e-05	0.00052	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.13e-05	0.000518	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.04e-05	0.000495	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2e-05	0.000486	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2e-05	0.000485	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.89e-05	0.00046	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.88e-05	0.000455	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—AVP—type 2 diabetes mellitus	1.85e-05	0.000449	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.85e-05	0.000449	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.84e-05	0.000447	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.83e-05	0.000445	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.82e-05	0.000441	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—APOB—type 2 diabetes mellitus	1.79e-05	0.000434	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.78e-05	0.000432	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.76e-05	0.000427	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—LPL—type 2 diabetes mellitus	1.71e-05	0.000415	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.67e-05	0.000406	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.6e-05	0.000389	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.57e-05	0.000382	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—C3—type 2 diabetes mellitus	1.54e-05	0.000373	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.47e-05	0.000356	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.46e-05	0.000355	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.46e-05	0.000355	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.44e-05	0.000349	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.43e-05	0.000348	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.43e-05	0.000348	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.41e-05	0.000344	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.35e-05	0.000328	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.28e-05	0.00031	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.22e-05	0.000297	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.2e-05	0.000292	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.18e-05	0.000287	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.18e-05	0.000287	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.18e-05	0.000286	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.12e-05	0.000273	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.07e-05	0.00026	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.07e-05	0.00026	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.01e-05	0.000245	CbGpPWpGaD
Mephentermine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.19e-06	0.000223	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.1e-06	0.000221	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.04e-06	0.00022	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.6e-06	0.000209	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.51e-06	0.000207	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.34e-06	0.000203	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	7.93e-06	0.000193	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.73e-06	0.000188	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.09e-06	0.000172	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.95e-06	0.000169	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.34e-06	0.00013	CbGpPWpGaD
Mephentermine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.93e-06	0.00012	CbGpPWpGaD
